Stocktwits on MSN

Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise

VKTX shares have surged about 45% in October, set for their strongest monthly gain of 2025. ・Traders on Stocktwits linked ...

Viking Therapeutics Q3 Earnings: What We Learned (And Why We Should Keep Faith)

Discover why Viking Therapeutics, Inc.'s VK2735 could lead GLP-1 obesity drugs. Click for my updated look at VKTX stock ...
BioSpace

MASH, Metsera Deals Send Analysts Marauding to Viking

Viking Therapeutics CEO Brian Lian is watching the growth of interest in MASH and obesity but prepared to go it alone.

Viking Therapeutics stock rises ahead of obesity drug presentations at medical conferences

Investing.com -- Viking Therapeutics Inc (NASDAQ:VKTX) stock jumped 7.3% following the announcement that its VK2735 obesity program will be featured in multiple presentations at upcoming medical ...